Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5	14	23	87	20	19
Market Cap Growth	-81.75%	-38.61%	-73.66%	339.65%	6.77%	301.65%
Enterprise Value	-7	-1	-28	-4	-20	5
PE Ratio	-	-0.29	-0.50	-2.66	-0.97	-1.48
PB Ratio	0.73	1.93	0.46	0.93	0.49	1.19
P/FCF Ratio	-0.30	-0.34	-0.65	-2.77	-1.22	-2.43
P/OCF Ratio	-0.30	-0.34	-0.65	-2.78	-1.22	-2.45
EV/EBITDA Ratio	0.05	0.01	0.63	0.13	1.00	-0.73
EV/EBIT Ratio	0.05	0.01	0.63	0.13	1.00	-0.73
EV/FCF Ratio	0.06	0.01	0.81	0.13	1.24	-0.71
Debt / Equity Ratio	0.02	0.03	0.00	0.00	0.02	0.05
Debt / EBITDA Ratio	0.00	0.00	0.00	-0.01	-0.04	-0.11
Debt / FCF Ratio	0.00	-0.01	0.00	-0.01	-0.05	-0.11
Quick Ratio	5.09	2.80	6.49	11.13	8.74	8.65
Current Ratio	6.00	3.31	7.16	11.88	9.15	8.94
Interest Coverage	-3644.86	-5211.37	-4434.65	-3692.66	-649.78	-13.32
Return on Equity (ROE)	-268.70%	-225.00%	-68.90%	-30.90%	-90.00%	-98.80%
Return on Assets (ROA)	-161.20%	-151.60%	-58.60%	-28.50%	-70.00%	-68.50%
Return on Capital (ROIC)	-525.17%	-646.85%	-91.14%	-32.58%	-48.81%	-47.31%
Earnings Yield	-705.51%	-348.13%	-198.05%	-37.66%	-103.01%	-67.42%
FCF Yield	-664.95%	-291.04%	-152.79%	-36.08%	-82.22%	-41.14%
Buyback Yield / Dilution	-33.09%	-4.18%	-8.45%	-626.31%	-373.65%	-1011.18%
Total Shareholder Return	-33.09%	-4.18%	-8.45%	-626.31%	-373.65%	-1011.18%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).